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ABSTRACT 
The aim of this study was using a temporary collagen punctal plug as a pre-test before decision of permanent punctal 
closure or long-term plug use for patients with dry eye disease (DED) and primary open-angle glaucoma (POAG). This 
case-control study was conducted at a single office in Honolulu, Hawaii from January 2017 to August 2018. In the case 
group, a temporary collagen plug was used in 33 eyes of 33 patients with DED and POAG who were receiving glaucoma 
medications with good control. On the other hand in the control group, 33 eyes of 33 patients with DED and POAG who 
were receiving glaucoma medications with good control were included, but punctal plug was not used. In the case group, 
one of the lower lid puncta was selected for the study and a canalicular rod shape plug was inserted as a therapeutic trial 
to predict the efficacy of long-term punctal plug placement or punctal closure. The mean changes of intraocular pressure 
(IOP) and improvement in symptoms/signs of DED were compared between the two study groups. Results revealed a 
statistically significant IOP reduction in the case group compared to the control group. Furthermore, DED improved 
significantly more in the case group compared to the control group (P< 0.001). We concluded that temporary punctal 
plug in patients with DED and POAG can significantly improve DED and lower IOP. Therefore, we could consider 
permanent punctal closure or long-term plug for patients with DED and POAG who responded well to temporary punctal 
plug without epiphora or other complications. 
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INTRODUCTION
The incidence of dry eye disease (DED) has been reported as 
7.4% to 33.7%, predominantly found in females and the 
elderly [1]. Punctal plug occlusion has been reported as an 
effective treatment for dry eyes by some studies [2].
 
Song et 
al. in a systematic review reported one of the 
misconceptions about punctal plugs reporting that they may 
be effective primarily in DED with aqueous deficiency. 
Several studies demonstrated that plugs are effective in 
various ocular DEDs [3]. Treatment of patients with DED and 
primary open-angle glaucoma (POAG) can be challenging as 
topical intraocular pressure (IOP) lowering medications used 
to treat glaucoma can also worsen signs and symptoms of 
DED. Matthews et al. reported that 45-60% of patients with 
glaucoma using topical hypotensive medications have some 
degrees of ocular surface disease [4]. 
 Punctal occlusion can improve DED and also glaucoma by 
increasing retention of IOP-lowering medications. Besides, 
punctal occlusion can decrease absorption of glaucoma 
medications into nasal mucosae, such as beta-blockers to 
prevent affecting the heart rate. One study demonstrated 
that punctal occlusion reduces 60% of systemic absorption 
of topical timolol [5]. Also, Huang et al. found a statistically 
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significant reduction in IOP after punctal plug occlusion 
with a difference of 1.82 mmHg or 10.7% (baseline of 
16.96 mmHg) [6].
 
Nonetheless, some clinical studies found 
questionable efficacy regarding glaucoma therapy using 
punctal plug [7, 8].
 
Although punctal plug placement is 
safe, epiphora, conjunctival irritation and punctal plug 
extrusion have been reported as most common 
complications. Canaliculitis and dacryocystitis, which are 
caused by Actinomyces israelii, Staphylococci, Streptococci 
and Diphtheroids are also infrequent [9]. Both 
intracanalicular plugs and external plug can be 
inadvertently pushed down into the canaliculus during 
insertion. Besides, an external plug can be lost after 
insertion. Therefore, a temporary fast absorbable collagen 
plug can be used as a pre-test before considering long-
term punctal plugs or permanent closure to avoid these 
complications. The temporary absorbable intracanalicular 
collagen plug will be absorbed in two days to two weeks 
[10, 11].
 
This study aimed to investigate whether absorbable 
intracanalicular collagen temporary punctal plug inserted 
in patients with DED and POAG can improve patients’ 
ocular surface disease and improve the efficacy of topical 
IOP lowering medications without complications.  
METHODS 
This was a case-control study conducted from January 
2017 to August 2018. The study protocol was approved by 
the institutional review committee of the University of 
Hawaii. All study participants gave a written informed 
consent. In the case group, the temporary plug was used 
in 33 eyes of 33 patients who had well-controlled chronic 
POAG and DED, while receiving IOP lowering medications 
such as Timolol or latanoprost. One of the lower lid puncta 
was selected for the study. However, in the control group, 
33 eyes of 33 patients with chronic POAG and DED and 
receiving their IOP lowering medications such as Timolol or 
latanoprost were recruited, but plug was not used. Eyes 
with POAG were confirmed clinically by IOP above 20 
mmHg, open-angle in the gonioscopic examination, visual 
field defect on Humphrey visual field test (Carl Zeiss 
Meditec, Jena, Germany) and objective findings in Optical 
Coherence Tomography (OCT) (Stratus-OCT Zeiss, Jena, 
Germany) imaging.  
The inclusion criteria were adults (50-90-years-old) with 
DED and well-controlled chronic POAG with IOP in normal 
range while using their topical IOP lowering medications. 
The exclusion criteria were severe and poorly controlled 
POAG, severe ocular surface disease, chronic 
dacryocystitis, nasolacrimal duct obstruction, history of  
lacrimal, glaucoma or refractive surgery, history of contact 
lens wear and those who could not adhere to follow-up at 
two weeks. 
In  the cases group, a canalicular rod shape plug was 
inserted for a temporary therapeutic trial (Figure 1) to 
predict long-term punctal plug placement or punctal 
closure. Punctal plug was selected  according to the size of 
vertical canalicular soft collagen plug (from 0.3 to 0.5 mm 
diameter, Oasis, Lacrimedics, Glendora, Ca, The USA)  that 
was easily but tightly inserted into the punctum without 
dilation [11].  
 
Figure 1: Insertion of Vertical Canalicular Soft Collagen Plug in Left Lower 
Punctum in Case Group 
 
IOP was checked by a single technician (M.C.) using a non-
contact tonometer called Ocular Response Analyzer (ORA) 
(Reichert Ophthalmic Instruments Inc., Depew, NY) and 
the corneal compensated IOP (IOP-CC) considered for 
analysis. IOP measurement was performed at the same 
office visit time before and 2 weeks after a temporary 
punctal plug insertion in the case group and at first visit 
and after two weeks follow-up in the control group. 
Symptom improvement was checked according to the 
OSDI (Ocular Surface Disease Index) criteria including light 
sensitivity, gritty sensation, pain and blurring of vision. 
Moreover, TFOS DEWSI (The international Tear Film and 
Ocular Surface Society Dry Eye Workshop I) dry eye 
diagnostic criteria was used [12].
 
Improvement of cornea 
stain and tear break up time (TBUT) were assessed as the 
outcome measures (Figures 2-3).  
Descriptive statistics using frequency and percentage for 
categorical variables, and mean and standard deviation 
(SD) for continuous variables were calculated. Fisher’s 
exact test and two-sample t-test were used. All statistical 
tests were two-sided and p-value < 0.05 was considered 
as statistically significant. R software, version 3.6.0 (R 
Core Team, 2019) was used to analyze data. 
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Figure2: Slit-photo Under Diffuse Illumination With Blue Cobalt Light 
Before Insertion of the Punctual Plug in the Case Group, Showing 
Diffuse Punctate Epithelial Staining of the Cornea. 
 
Figure 3: Slit-photo Under Diffuse Illumination With Blue Cobalt Light 
Two Weeks Following Insertion of the Punctual Plug in the Case 
Group, Showing Less Punctate Epithelial Staining of the Cornea. 
Table 1:Demographic Characteristics and Final Evaluations of Case and Control Groups  
 
 
Abbreviations: SD: standard deviation; n: number; %: percentage; E2: left lower lid punctum; E4: right lower lid punctum; OS: left eye; OD: right eye; 
DED: dry eye disease; mm: millimeter; IOP: intraocular pressure; S&S: symptom  and sign; OSDI: Ocular Surface Disease Index; Case group: subjects with 
punctal plug; Control group: subjects without punctal plug. P<0.05 in bold. 
 
Variable Case Group 
Eyes Treated with Punctum Plug (n=33) 
n (%) or Mean ± SD 
 
Control Group 
Eyes Treated without Punctum Plug (n=33) 
n (%) or Mean ± SD 
p-value 
Sex   0.999 
   Male 15 (45.45%) 14 (42.42%)  
   Female 18 (54.55%) 19 (57.58%)  
Age 76.97 ±  7.35 75.33 ± 9.22 0.428 
Location    
   E2 (OS); Left 20 (60.61%) Not Applied  
   E4 (OD); Right 13 (39.39%) 
Dry Eye Disease level    
   DED 1 1 (3.03%) 22 (66.67%) <0.001  
   DED 2 23 (69.70%) 5 (15.15%) <0.001  
   DED 3 8 (24.24%) 5 (15.15%) 0.325 
   DED 4 1 (3.03%) 1 (3.03%) 0.754 
Punctum Size (mm)    
   0.3 2 (6.06%) Not Applied  
   0.4 7 (21.21%) 
   0.5 24 (72.73%) 
Eyes with IOP Change    
   Decreased 22 (66.67%) 
-4.18 ± 2.74 
18 (54.55%)  
-2.94 ± 2.07 
0.531 
 
   Same 3 (9.09%) 6 (18.18%)  0.052 
   Increased 8 (24.24%) 
2.00 ± 1.41 
9 (27.27%) 
4.11 ± 3.55 
0.522 
Improvement of symptom and signs Less corneal staining No change  
   Same 5 (15.15%) 31 (93.94%) <0.001 
   Improved 28 (84.85%) 2 (6.06%) <0.001 
Mean OSDI score 20.24   30.21 0.189 
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Table2: Baseline and Final Intraocular Pressure (IOP) of the Case and Control Groups 




IOP at First Visit; mmHg 17.09±4.58 13.94±3.42 
IOP at Second Visit  (2 weeks later); mmHg 14.39±3.18 13.45±3.46 
IOP difference; mmHg -2.7±3.53 -0.48±3.85 
The final IOP was significantly lower in the case group (paired t-test, p-value=0.0001), yet not in the control group (paired t-test; p-value=0.4746). Abbreviations: 
SD: standard deviation; mmHg: millimeters of mercury; Case group: subjects with punctal plug; Control group: subjects without punctal plug. 
 
RESULT 
Thirty-three eyes of 33 patients in the case and 33 eyes 
of 33 patients in the control group with the mean ± SD 
age of 76.97 ± 7.35 and 75.33 ± 9.22 years, respectively 
were evaluated (Table 1). The two groups were age-sex 
matched with P-values of 0.428 and 0.999, respectively. 
In the case group, 20 (60.61%) eyes had punctal plug of 
the left lower lid and 13 (39.39%) in the right lower lid 
(Table 1). According to the severity of DED in each study 
group, patients were divided into four subgroups 
including DED 1, DED 2, DED 3 and DED 4. In case and 
control groups, 1 (3.03%) and 22 (66.67%) eyes 
considered as DED 1, 23 (69.70%) and 5 (15.15%) eyes as 
DED 2, 8 (24.24%) and 5 (15.15%) eyes as DED 3, and 1 
(3.03%) and 1 (3.03%) eye as DED 4, respectively. The 
number of patients with DED 1 and DED 2 in the case 
group was significantly different from the control group 
(P<0.001). Punctal diameter in the case group were as 
follows; in 24 (72.73%) eyes was 0.5 mm, in 7 (21.21%) 
eyes 0.4 mm and in 2 (6.06%) eyes 0.3 mm (Table 1). 
Evaluating signs and symptoms of DED two weeks after 
the study showed that in the case group 28 eyes 
(84.85%) and in the control group only two eyes (6.06%) 
had improvement, with a statistically significant 
difference. Also, the case group had a lower OSDI score 
compared to the control group, which indicates 
improvement in ocular surface disease index in the case 
group (20.24 versus 30.21) (Table 1). At the end of study, 
we evaluated changes in IOP between the two groups as 
well as between baseline and final IOP in each group. 
Although, the number of eyes did not differ significantly 
between the groups with decreasing IOP, increasing IOP 
and constant IOP (Table 1). However as shown in Table 2, 
the final IOP in the case group was significantly lower 
than the baseline (P=0.001), but not in the control group 
(P=0.474). 
DISCUSSION 
In the current study, we found that temporary collagen 
punctum plug can reduce IOP and improve symptoms 
and signs of DED without the risk of permanent punctum 
closure. We intended to develop this test to avoid 
irreversible complications from permanent punctal 
closure. 
 It is well known that punctal plug can improve DED and 
reduce IOP in patients with glaucoma [3, 6]. Sherwin et 
al. also indicated the efficacy of punctal plug to control 
IOP and improve DED. However, they inserted a pre-
loaded silicone punctal plug [13], whereas in the current 
study we used a vertical canalicular soft collagen plug. 
The silicon plug is more expensive, irritable and with the 
possibility of loss after insertion. Also, permanent punctal 
plug may cause irreversible epiphora [9]. A short-term 
economical collagen plug may be an option before 
placing permanent or semi-permanent silicone plugs. 
Collagen absorbable plugs are made of bovine collagen, 
which is generally well-tolerated. However, 
approximately 3% of population is allergic to bovine 
collagen [14, 15].
 
Ahn et al. reported a case of 
canaliculitis three years after the insertion of plug [15]. 
Mullins reported two cases with allergic reaction to 
bovine collagen [16]. Fortunately in our study, no allergic 
reaction was reported.  
Patients in our trial were receiving treatment for both 
DED and glaucoma during the study, therefore, the 
validity of our results may be affected by some 
confounding factors such as compliance, age, other 
comorbidities and finance [17]. However, the result of 
this study matched previous studies using punctal plug 
[2, 6]. Totally, 45-60% of patients with glaucoma using 
topical IOP lowering medications have an ocular surface 
disease, therefore clinicians must consider punctal plug 
as one of the adjunct treatment for these patients. Some 
studies have reported that plugs are effective in a variety 
of ocular diseases, not just aqueous deficiency DED [3].
   
This was the first study regarding temporary collagen 
punctal plug on lowering IOP and improving DED. Before 
placing an expensive silicon plug or permanent thermal 
punctal closure, an irreversible tearing from punctal 
closure or wasting an expensive non-effective silicon plug 
must be kept in mind. Here, a non-expensive temporary 
collagen plug was used to predict the efficacy of long-
term ones and assess possible complications.The 
limitations of this study were its single-center design by a 
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single physician, short time follow-up and not using the 
counterpart eye of each subject as the control group. The 
strength of this study was unified observation by a single 
physician and single automatic tonometry for IOP check. 
Further multicenter prospective double-blind studies 
may be needed to confirm the confidentiality of findings. 
CONCLUSION 
A temporary collagen punctal plug could improve DED 
and reduce IOP. In those eyes that responded to 
temporary plug without complications, a long-term 
punctal plug or permanent punctal closure could be 
considered.  
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